Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs NEULAND LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN NEULAND LABS LUPIN/
NEULAND LABS
 
P/E (TTM) x 40.7 25.4 160.3% View Chart
P/BV x 6.0 8.1 73.8% View Chart
Dividend Yield % 0.2 0.2 155.3%  

Financials

 LUPIN   NEULAND LABS
EQUITY SHARE DATA
    LUPIN
Mar-23
NEULAND LABS
Mar-23
LUPIN/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs7992,004 39.9%   
Low Rs583966 60.4%   
Sales per share (Unadj.) Rs365.8928.4 39.4%  
Earnings per share (Unadj.) Rs9.8127.4 7.7%  
Cash flow per share (Unadj.) Rs29.2168.6 17.3%  
Dividends per share (Unadj.) Rs4.0010.00 40.0%  
Avg Dividend yield %0.60.7 86.0%  
Book value per share (Unadj.) Rs270.7774.8 34.9%  
Shares outstanding (eoy) m454.9812.83 3,546.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.91.6 118.1%   
Avg P/E ratio x70.211.7 602.7%  
P/CF ratio (eoy) x23.78.8 268.7%  
Price / Book Value ratio x2.61.9 133.2%  
Dividend payout %40.77.8 518.1%   
Avg Mkt Cap Rs m314,38119,052 1,650.1%   
No. of employees `000NANA-   
Total wages/salary Rs m30,8722,018 1,529.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,41711,912 1,397.1%  
Other income Rs m1,50997 1,548.1%   
Total revenues Rs m167,92612,009 1,398.3%   
Gross profit Rs m17,2062,718 632.9%  
Depreciation Rs m8,807528 1,668.7%   
Interest Rs m2,743131 2,099.2%   
Profit before tax Rs m7,1652,157 332.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,688522 514.7%   
Profit after tax Rs m4,4771,635 273.8%  
Gross profit margin %10.322.8 45.3%  
Effective tax rate %37.524.2 155.0%   
Net profit margin %2.713.7 19.6%  
BALANCE SHEET DATA
Current assets Rs m124,5137,609 1,636.4%   
Current liabilities Rs m92,6544,390 2,110.8%   
Net working cap to sales %19.127.0 70.8%  
Current ratio x1.31.7 77.5%  
Inventory Days Days266 412.1%  
Debtors Days Days981,109 8.9%  
Net fixed assets Rs m103,4908,189 1,263.8%   
Share capital Rs m910129 705.4%   
"Free" reserves Rs m122,2469,812 1,245.9%   
Net worth Rs m123,1569,941 1,238.9%   
Long term debt Rs m275742 37.1%   
Total assets Rs m228,00315,798 1,443.3%  
Interest coverage x3.617.5 20.6%   
Debt to equity ratio x00.1 3.0%  
Sales to assets ratio x0.70.8 96.8%   
Return on assets %3.211.2 28.3%  
Return on equity %3.616.4 22.1%  
Return on capital %8.021.4 37.5%  
Exports to sales %073.5 0.0%   
Imports to sales %015.1 0.0%   
Exports (fob) Rs mNA8,750 0.0%   
Imports (cif) Rs mNA1,804 0.0%   
Fx inflow Rs m48,0578,750 549.2%   
Fx outflow Rs m21,7521,804 1,205.7%   
Net fx Rs m26,3066,946 378.7%   
CASH FLOW
From Operations Rs m18,9722,372 799.8%  
From Investments Rs m-12,868-615 2,092.3%  
From Financial Activity Rs m-3,373-1,358 248.4%  
Net Cashflow Rs m2,732403 677.5%  

Share Holding

Indian Promoters % 46.8 32.8 142.6%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 45.8 29.1 157.4%  
FIIs % 16.1 22.7 71.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 67.2 78.8%  
Shareholders   281,542 27,723 1,015.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs NEULAND LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs NEULAND LABS Share Price Performance

Period Lupin NEULAND LABS S&P BSE HEALTHCARE
1-Day 1.23% -1.12% 1.18%
1-Month 0.15% -11.56% -0.75%
1-Year 151.14% 269.91% 61.82%
3-Year CAGR 17.13% 43.81% 18.16%
5-Year CAGR 17.42% 59.26% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the NEULAND LABS share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of NEULAND LABS the stake stands at 32.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of NEULAND LABS.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

NEULAND LABS paid Rs 10.0, and its dividend payout ratio stood at 7.8%.

You may visit here to review the dividend history of Lupin, and the dividend history of NEULAND LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.